This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.

Search the website

Medicines, medical devices and life sciences

We help medical device manufacturers, pharmaceutical companies, NHS bodies, investors and innovators to get their products to patients.

Closeup Shot Of Microscope With Metal Lens At Laboratory

Our lawyers will listen.

Then we will work with you to create a practical path for legal issues that drives medical products forward, from concept, development, approval and accreditation to adoption and deployment at scale. We understand that innovation – be that digital health or medical devices, to novel therapeutics and pioneering diagnostics – may need news ways of working to break down barriers to market access.

Our experience working with leading NHS Trusts, central Government and industry means we know the levers, constraints and ways of working that are likely to lead to success. Whether you are bringing new products to market, revolutionising pathways or expanding your business, we can help you navigate legal issues across the healthcare and life sciences sector, including regulatory compliance, AI, health data, IP, commercial, corporate and procurement.

Services

Regulatory compliance

Advising on requirements from pre-market authorisation to post-market surveillance for medical devices, health tech and digital solutions, including interactions with MHRA, General Pharmaceutical Council, CQC and other regulators.

Service user/patient terms

Ensuring compliance with healthcare, medical regulatory, advertising, digital and consumer law, as well as national guidelines.

Software and AI

Lawyers with specialist AI-law training applying emerging regulation on software and AI to your business.

Data and information governance

Including data protection law, healthcare specific guidance, Caldicott requirements and their application to data collection, storage and novel uses for developing medical technology.

Commercial agreements

Advising on strategic approach, drafting and negotiation of key contracts covering supply chain, distribution and commercialisation of products and services.

Partnerships and collaborations

Advising on models for industry, NHS, funders, third sector and other stakeholders to work together to bring innovation to market.

Procurement

Helping industry and the NHS use the new procurement law regime to drive adoption of new technology and products, including solutions to perceived barriers to participation and deployment at scale.

Intellectual property

Protecting IPR rights at each stage of a product lifecycle, including when working with multiple funding streams and innovative partnership/collaboration models.

Competition law

Advising on competition law issues.

Raising investment

Advising on early stage, venture capital, growth capital, development capital and venture debt transactions.

Examples of our work

Global pharmaceutical company

Advising on a range of issues relating to drug manufacture and supply, including distribution, licence, commercialisation, regulatory and manufacture agreements covering UK, EU and non-EU markets.

UK Government

Advising on contracts to manufacture vaccines as part of UK’s response to the COVID-19 pandemic and advising UKHSA on ongoing Covid vaccine procurement as part of 2025+.

Leading NHS Foundation Trust

Advising on a range of clinical and non-clinical services contracts in the UK and internationally, collaborations with industry, health tech adoption, drug supply arrangements and procurement issues.

International telemedicine provider

Advising on UK market access and expansion, interactions with MHRA, NICE and issues relating to the import, distribution and sale of medicines in the UK and via Windsor Framework, including on stock shortage, licence variations and registration requirements.

Innovate UK

Advising on a collaborative grant funding programme with medical charity Life Arc and the Medicines Discovery Catapult to deliver the PACE programme supporting antimicrobial resistance (AMR) innovations.

Global medical device manufacturers

Advising on range of issues linked to supply, manufacture and procurement in the UK, including contracts with NHS Trusts, NHS Supply Chain frameworks and regulatory issues.

01
06

What others say

“Having worked on many of these deals it’s great to have counsel who can see a practical path which the law can support.”

Pharmaceutical company CEO

“The team are approachable, take the time to explain their advice and deliver swift turnaround times, along with excellent negotiation skills.”

Chambers UK 2025

“The team has broad sector knowledge and provides practical, solution-focused, well-presented advice. ”

Legal 500 UK 2025

01
03